Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

160 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Prophylaxis against disseminated Mycobacterium avium complex with weekly azithromycin, daily rifabutin, or both. California Collaborative Treatment Group.
Havlir DV, Dubé MP, Sattler FR, Forthal DN, Kemper CA, Dunne MW, Parenti DM, Lavelle JP, White AC Jr, Witt MD, Bozzette SA, McCutchan JA. Havlir DV, et al. Among authors: forthal dn. N Engl J Med. 1996 Aug 8;335(6):392-8. doi: 10.1056/NEJM199608083350604. N Engl J Med. 1996. PMID: 8676932 Free article. Clinical Trial.
The tolerance for zidovudine plus thrice weekly or daily trimethoprim-sulfamethoxazole with and without leucovorin for primary prophylaxis in advanced HIV disease. California Collaborative Treatment Group.
Bozzette SA, Forthal D, Sattler FR, Kemper C, Richman DD, Tilles JG, Leedom J, McCutchan JA. Bozzette SA, et al. Among authors: forthal d. Am J Med. 1995 Feb;98(2):177-82. doi: 10.1016/s0002-9343(99)80401-x. Am J Med. 1995. PMID: 7847434 Clinical Trial.
Sequencing of protease inhibitor therapy: insights from an analysis of HIV phenotypic resistance in patients failing protease inhibitors.
Kemper CA, Witt MD, Keiser PH, Dubé MP, Forthal DN, Leibowitz M, Smith DS, Rigby A, Hellmann NS, Lie YS, Leedom J, Richman D, McCutchan JA, Haubrich R; California Collaborative Treatment Group #575 Team. Kemper CA, et al. Among authors: forthal dn. AIDS. 2001 Mar 30;15(5):609-15. doi: 10.1097/00002030-200103300-00010. AIDS. 2001. PMID: 11316998
The clinical relevance of non-nucleoside reverse transcriptase inhibitor hypersusceptibility: a prospective cohort analysis.
Haubrich RH, Kemper CA, Hellmann NS, Keiser PH, Witt MD, Forthal DN, Leedom J, Leibowitz M, Whitcomb JM, Richman D, McCutchan JA; California Collaborative Treatment Group. Haubrich RH, et al. Among authors: forthal dn. AIDS. 2002 Oct 18;16(15):F33-40. doi: 10.1097/00002030-200210180-00001. AIDS. 2002. PMID: 12370520 Clinical Trial.
A randomized study of the utility of human immunodeficiency virus RNA measurement for the management of antiretroviral therapy.
Haubrich RH, Currier JS, Forthal DN, Beall G, Kemper CA, Johnson D, Dubé MP, Hwang J, Leedom JM, Tilles J, McCutchan JA; California Collaborative Treatment Group. Haubrich RH, et al. Among authors: forthal dn. Clin Infect Dis. 2001 Oct 1;33(7):1060-8. doi: 10.1086/322636. Epub 2001 Sep 5. Clin Infect Dis. 2001. PMID: 11528581 Clinical Trial.
Prophylaxis with weekly versus daily fluconazole for fungal infections in patients with AIDS.
Havlir DV, Dubé MP, McCutchan JA, Forthal DN, Kemper CA, Dunne MW, Parenti DM, Kumar PN, White AC Jr, Witt MD, Nightingale SD, Sepkowitz KA, MacGregor RR, Cheeseman SH, Torriani FJ, Zelasky MT, Sattler FR, Bozzette SA. Havlir DV, et al. Among authors: forthal dn. Clin Infect Dis. 1998 Dec;27(6):1369-75. doi: 10.1086/515018. Clin Infect Dis. 1998. PMID: 9868644 Clinical Trial.
160 results